109 related articles for article (PubMed ID: 15508446)
1. [The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma].
Fujii K; Okamoto S; Saitoh K; Sasaki N; Takano M; Tanaka S; Kudoh K; Kita T; Tode T; Kikuchi Y
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1537-40. PubMed ID: 15508446
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of arthralgia and myalgia from paclitaxel and carboplatin combination chemotherapy with Shakuyaku-kanzo-to].
Fujiwara H; Urabe T; Ueda K; Mizunoe T; Date K; Nakano M; Honda N; Sakashita T; Fujito N
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1061-4. PubMed ID: 10925696
[No Abstract] [Full Text] [Related]
3. Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice.
Hidaka T; Shima T; Nagira K; Ieki M; Nakamura T; Aono Y; Kuraishi Y; Arai T; Saito S
Eur J Pain; 2009 Jan; 13(1):22-7. PubMed ID: 18472288
[TBL] [Abstract][Full Text] [Related]
4. Effects of shakuyaku-kanzo-to on muscle pain from combination chemotherapy with paclitaxel and carboplatin.
Yamamoto K; Hoshiai H; Noda K
Gynecol Oncol; 2001 May; 81(2):333-4. PubMed ID: 11330975
[No Abstract] [Full Text] [Related]
5. [The effect of L-Glutamine and Shakuyaku-Kanzo-to for paclitaxel-induced myalgia/arthralgia].
Hasegawa K; Mizutani Y; Kuramoto H; Nagao S; Masuyama H; Hongo A; Kodama J; Yoshinouchi M; Hiramatsu Y; Kudo T; Okuda H
Gan To Kagaku Ryoho; 2002 Apr; 29(4):569-74. PubMed ID: 11977541
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer.
Yoshida T; Sawa T; Ishiguro T; Horiba A; Minatoguchi S; Fujiwara H
Support Care Cancer; 2009 Mar; 17(3):315-20. PubMed ID: 18839222
[TBL] [Abstract][Full Text] [Related]
7. [Combined chemotherapy with weekly paclitaxel and carboplatin for recurrent and refractory epithelial ovarian cancer--phase I study].
Misawa A; Yasuda M
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1445-52. PubMed ID: 17033235
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study on the efficacy of weekly paclitaxel administration for platinum-resistant epithelial ovarian carcinoma].
Fujii K; Takano M; Okamoto S; Sasaki N; Kita T; Kikuchi Y
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2141-4. PubMed ID: 15628759
[TBL] [Abstract][Full Text] [Related]
9. [Neurotoxicity of weekly TP (weekly paclitaxel + consecutive low-dose CDDP) therapy].
Tate S; Hirai Y; Iwasaki H; Matsui H; Sekiya S; Hasumi K
Gan To Kagaku Ryoho; 2004 Jan; 31(1):67-73. PubMed ID: 14750324
[TBL] [Abstract][Full Text] [Related]
10. [Practical use of taxol-based chemotherapy for poor compliance gynecologic cancers in Japanese woman].
Mitsui M; Takashi K; Imai K
Gan To Kagaku Ryoho; 2003 Mar; 30(3):383-9. PubMed ID: 12669398
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
Pfisterer J; Weber B; Reuss A; Kimmig R; du Bois A; Wagner U; Bourgeois H; Meier W; Costa S; Blohmer JU; Lortholary A; Olbricht S; Stähle A; Jackisch C; Hardy-Bessard AC; Möbus V; Quaas J; Richter B; Schröder W; Geay JF; Lück HJ; Kuhn W; Meden H; Nitz U; Pujade-Lauraine E; ;
J Natl Cancer Inst; 2006 Aug; 98(15):1036-45. PubMed ID: 16882940
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.
Alberts DS; Marth C; Alvarez RD; Johnson G; Bidzinski M; Kardatzke DR; Bradford WZ; Loutit J; Kirn DH; Clouser MC; Markman M;
Gynecol Oncol; 2008 May; 109(2):174-81. PubMed ID: 18314182
[TBL] [Abstract][Full Text] [Related]
13. A case of pure-type ovarian squamous cell carcinoma for which combination chemotherapy consisting of paclitaxel and carboplatin was not effective.
Todo Y; Minobe S; Sasaki M; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Apr; 97(1):223-7. PubMed ID: 15790463
[TBL] [Abstract][Full Text] [Related]
14. A comparative study on hematological effects of carboplatin plus cyclophosphamide and carboplatin plus paclitaxel chemotherapy for the first line treatment of epithelial ovarian cancer.
Vapattanawong P
J Med Assoc Thai; 2006 Sep; 89(9):1357-61. PubMed ID: 17100369
[TBL] [Abstract][Full Text] [Related]
15. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F
Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011
[TBL] [Abstract][Full Text] [Related]
17. Effect of orally administered shao-yao-gan-cao-tang (Shakuyaku-kanzo-to) on muscle cramps in maintenance hemodialysis patients: a preliminary study.
Hinoshita F; Ogura Y; Suzuki Y; Hara S; Yamada A; Tanaka N; Yamashita A; Marumo F
Am J Chin Med; 2003; 31(3):445-53. PubMed ID: 12943175
[TBL] [Abstract][Full Text] [Related]
18. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
Zhao XD; Zhang Q; Zhang Y
Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of adverse effects including neurotoxicity of combination chemotherapy with paclitaxel and carboplatin].
Tate S; Iwasaki H; Matsui H; Hirai Y; Sekiya S
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2087-95. PubMed ID: 11103240
[TBL] [Abstract][Full Text] [Related]
20. Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens.
du Bois A; Weber B; Rochon J; Meier W; Goupil A; Olbricht S; Barats JC; Kuhn W; Orfeuvre H; Wagner U; Richter B; Lueck HJ; Pfisterer J; Costa S; Schroeder W; Kimmig R; Pujade-Lauraine E; ; ;
J Clin Oncol; 2006 Mar; 24(7):1127-35. PubMed ID: 16505432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
